News

Biotectix Licenses Conductive Polymer Precursor to Sigma-Aldrich Corporation

25-Oct-2011
Ann Arbor, Michigan - Biotectix recently completed its first intellectual property license agreement with Aldrich Materials Science, a strategic technology initiative of Sigma-Aldrich Corporation. The agreement allows Aldrich Materials Science to manufacture and sell, for research purposes, a proprietary functionalized Ethylenedioxythiophene (EDOT) monomer used in the production of electrically conductive polymers. These polymers can be employed in a variety of applications including photovoltaics, thin film electronics and biosensors. 


About Aldrich Materials Science

Aldrich Materials Science provides performance materials for the Alternative Energy, Electronics and Biomedical markets. The Company enables innovation through its Centers of Excellence in Hard Materials, Polymers and Organic Electronics, via new materials to their catalog portfolio, custom research services, technology licensing, collaborations, process development and scale-up services. For more information, visit www.sigma-aldrich.com/matsci

About Biotectix

Biotectix is developing a new class of conductive polymer materials and coatings for implantable devices and sensors that improve the safety, longevity, reliability, biological integration, and function of implantable biomedical devices. A number of benefits are driven by this platform technology without changing device size, shape, or implant procedure, including improved electrical performance, biocompatibility, and tissue response. The technology addresses key limitations faced by the medical device industry including foreign body reactions, component stability, and long-term electrical performance in vivo. The materials are custom-designed for the specialized mechanical, electrical, and biological environments of the body, and provide an extremely high level of functional interfacing for medical electrodes. Biotectix was formed by Allied Minds, a private equity company, based on technology originally developed at the University of Michigan, Ann Arbor. The founders and inventors continue to develop and validate the technology through research, collaborations, and partnerships with leading companies and research institutions.  www.biotectix.com


For further questions or additional information please contact: 
James ArpsVice President & General Manager

The Latest Press

08-May-2012

Orange County Register - UCI: New device eases painful ringing in ears

(http://sciencedude.ocregister.com/2012/05/08/uci-new-device-eases-painful-ringing-in-ears/171385/soundcure/) by Pat Brennan - OC Register science, environ..

07-May-2012

Dan Espinal Joins Allied Minds as a Director of Federal Research

Boston, MA --- Allied Minds, Inc., a private equity firm that invests in early-stage technologies developed at renowned U.S. universities and federally funded research ins..

24-Apr-2012

Fast Company Magazine: How A Colorado Town's Med-Tech Startups Thrive On Shoestring Budgets

(http://www.fastcompany.com/1835136/montview-boulevard) by Garth Sundem In most cities, academic researchers have to drive across town, or even through othe..